181 related articles for article (PubMed ID: 10970892)
1. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.
Jin T; Gu Y; Zanusso G; Sy M; Kumar A; Cohen M; Gambetti P; Singh N
J Biol Chem; 2000 Dec; 275(49):38699-704. PubMed ID: 10970892
[TBL] [Abstract][Full Text] [Related]
2. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
[TBL] [Abstract][Full Text] [Related]
3. Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP.
Peters SL; Déry MA; LeBlanc AC
Hum Mol Genet; 2016 Mar; 25(5):976-88. PubMed ID: 26740554
[TBL] [Abstract][Full Text] [Related]
4. Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly' intracellular aggregates.
Gu Y; Verghese S; Bose S; Mohan M; Singh N
J Mol Neurosci; 2007; 32(1):90-6. PubMed ID: 17873292
[TBL] [Abstract][Full Text] [Related]
5. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein.
Zanusso G; Petersen RB; Jin T; Jing Y; Kanoush R; Ferrari S; Gambetti P; Singh N
J Biol Chem; 1999 Aug; 274(33):23396-404. PubMed ID: 10438517
[TBL] [Abstract][Full Text] [Related]
7. Enhanced binding to the molecular chaperone BiP slows thyroglobulin export from the endoplasmic reticulum.
Muresan Z; Arvan P
Mol Endocrinol; 1998 Mar; 12(3):458-67. PubMed ID: 9514162
[TBL] [Abstract][Full Text] [Related]
8. Selective processing and metabolism of disease-causing mutant prion proteins.
Ashok A; Hegde RS
PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
[TBL] [Abstract][Full Text] [Related]
9. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
Apodaca J; Kim I; Rao H
Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
[TBL] [Abstract][Full Text] [Related]
10. Protein disulfide isomerase regulates endoplasmic reticulum stress and the apoptotic process during prion infection and PrP mutant-induced cytotoxicity.
Wang SB; Shi Q; Xu Y; Xie WL; Zhang J; Tian C; Guo Y; Wang K; Zhang BY; Chen C; Gao C; Dong XP
PLoS One; 2012; 7(6):e38221. PubMed ID: 22685557
[TBL] [Abstract][Full Text] [Related]
11. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.
Stewart RS; Drisaldi B; Harris DA
Mol Biol Cell; 2001 Apr; 12(4):881-9. PubMed ID: 11294893
[TBL] [Abstract][Full Text] [Related]
12. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.
Massignan T; Biasini E; Lauranzano E; Veglianese P; Pignataro M; Fioriti L; Harris DA; Salmona M; Chiesa R; Bonetto V
Mol Cell Proteomics; 2010 Apr; 9(4):611-22. PubMed ID: 19996123
[TBL] [Abstract][Full Text] [Related]
13. The metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions.
Negro A; Ballarin C; Bertoli A; Massimino ML; Sorgato MC
Mol Cell Neurosci; 2001 Mar; 17(3):521-38. PubMed ID: 11273647
[TBL] [Abstract][Full Text] [Related]
14. JPDI, a novel endoplasmic reticulum-resident protein containing both a BiP-interacting J-domain and thioredoxin-like motifs.
Hosoda A; Kimata Y; Tsuru A; Kohno K
J Biol Chem; 2003 Jan; 278(4):2669-76. PubMed ID: 12446677
[TBL] [Abstract][Full Text] [Related]
15. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Sträussler-Scheinker syndrome.
Gavin BA; Dolph MJ; Deleault NR; Geoghegan JC; Khurana V; Feany MB; Dolph PJ; Supattapone S
J Neurosci; 2006 Nov; 26(48):12408-14. PubMed ID: 17135402
[TBL] [Abstract][Full Text] [Related]
16. The effect of disease-associated mutations on the folding pathway of human prion protein.
Apetri AC; Surewicz K; Surewicz WK
J Biol Chem; 2004 Apr; 279(17):18008-14. PubMed ID: 14761942
[TBL] [Abstract][Full Text] [Related]
17. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
18. Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation.
Singh N; Zanusso G; Chen SG; Fujioka H; Richardson S; Gambetti P; Petersen RB
J Biol Chem; 1997 Nov; 272(45):28461-70. PubMed ID: 9353306
[TBL] [Abstract][Full Text] [Related]
19. Interaction of murine BiP/GRP78 with the DnaJ homologue MTJ1.
Chevalier M; Rhee H; Elguindi EC; Blond SY
J Biol Chem; 2000 Jun; 275(26):19620-7. PubMed ID: 10777498
[TBL] [Abstract][Full Text] [Related]
20. Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum.
Kim PS; Arvan P
J Cell Biol; 1995 Jan; 128(1-2):29-38. PubMed ID: 7822419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
